Neuroleptic Malignant Syndrome: Diagnostic and Therapeutic Dilemmas
Neuroleptic malignant syndrome (NMS) is a life threatening medical state complicating the use of antipsychotic medications and other drugs that affect the dopaminergic system on administration or withdrawal. The condition was recognised nearly half a century ago, shortly after the discovery of antip...
Saved in:
Main Authors: | Abebaw Fekadu, Jonathan I. Bisson |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2005-01-01
|
Series: | Behavioural Neurology |
Online Access: | http://dx.doi.org/10.1155/2005/471260 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neuroleptic Malignant Syndrome Caused by a Combination of Carbamazepine and Amitriptyline
by: A. Bruce Janati, et al.
Published: (2012-01-01) -
Diagnostic, Treatment, and System Challenges in the Management of Recurrent Neuroleptic Malignant Syndrome on a General Medical Service
by: Karan Verma, et al.
Published: (2018-01-01) -
Neuroleptic Malignant Syndrome: A Case Aimed at Raising Clinical Awareness
by: Jad Al Danaf, et al.
Published: (2015-01-01) -
Paliperidone Inducing Concomitantly Syndrome of Inappropriate Antidiuretic Hormone, Neuroleptic Malignant Syndrome, and Rhabdomyolysis
by: Jaspinder Kaur, et al.
Published: (2016-01-01) -
Neuroleptic Malignant Syndrome (NMS) on Clozapine with a Potential Atypical Interaction with Paliperidone
by: Paras Agarwal, et al.
Published: (2021-01-01)